Navigation Links
Infinity Bio-Energy Ltd. Announces 2008 Annual General Meeting
Date:6/16/2008

SAO PAULO, Brazil, June 17 /PRNewswire/ -- Pursuant to the BDR offering and BOVESPA Listing announcement released on June 06, 2008, Infinity Bio-Energy Ltd. has called a shareholders' meeting on June 25, 2008 at 10:00 a.m (Sao Paulo time) to approve new bye-laws conforming to Novo Mercado Standards, the election and re-election of new board directors and the presentation of auditors' reports and financial statements and other matters.

Novo Mercado is a special segment of the Brazilian Stock Exchange (BOVESPA) which requires high standards of Corporate Governance. Notwithstanding that the BDR offering does not demand the same Corporate Governance levels, the Company intends to incorporate the Novo Mercado standards, being governed by the proposed bye-laws. In order to achieve these standards, the Company invites all shareholders to vote on the 2008 Annual General Meeting.

The agenda is described below:

Notice

YOU ARE HEREBY NOTIFIED that the 2008 Annual General Meeting of the Company
will be held at Rua Funchal, 418, 22nd floor, Sao Paulo, SP, Brazil, on:

June 25, 2008 at 10:00 a.m. (Sao Paulo time)

AGENDA

1. Elect a Chairman of the General Meeting, if necessary.

2. Read Notice convening this meeting.

3. Minutes of the last General Meeting to be read and confirmed.

4. Presentation of Auditors' Report and Financial Statements for the

year ended March 31, 2008.

5. Presentation of Directors' Report to the Shareholders.

6. Appoint BDO as Auditor of the Company until the close of the next

Annual General Meeting and authorize the Board of Directors to

determine the remuneration of the Auditor.

7. Consider the election of Eduardo Bom Angelo, Alberto Mendes Tepedino

and Dimitri Marriette Henri Pauwels as Class III Directors, and

authorize them t
'/>"/>

SOURCE Infinity Bio-Energy Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Elekta Announces Elekta Infinity - a New System for Faster and More Precise Treatment of Cancer Tumors
2. EnzySurge, Maker of DermaStream(TM), Announces the Formation of its Scientific Advisory Board
3. Haemonetics Announces Launch of Faster Plasma Collection Protocol
4. Meritage Pharma, Inc. Announces Company Formation and $22.5M Series A Financing
5. Angiotech announces market launch of Quill(TM) SRS MONODERM(TM)
6. Exelixis Announces June 19 Webcast of Presentation at the William Blair 28th Annual Growth Stock Conference
7. Villa St. Benedict Announces New Web Site
8. BioNeutral Announces a BREAKTHROUGH in the Fight Against Bioterrorism
9. Indevus Announces Management Changes
10. Chindex International, Inc. Announces Fiscal 2008 Year End and Fourth Quarter Results
11. Cell Therapeutics, Inc. Announces Issuance of 2011 Convertible Senior Notes and Common Stock Warrants to a Single Institutional Investor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)... CITY , Nov. 18, 2014  Great Basin Scientific, ... today announced that the management will host a conference call ... and development programs on Thursday, Nov. 20, at 4:30 pm ... we have made since the Company,s recent IPO and would ... Great Basin,s management," said Ryan Ashton , President and ...
(Date:11/17/2014)... , Nov. 17, 2014 Soligenix, ... late-stage biopharmaceutical company developing products that address unmet ... and biodefense, announced today the formation of a ... guidance to the Company as it advances the ... for the treatment of cutaneous T-cell lymphoma (CTCL), ...
(Date:11/15/2014)... Collaborative Consulting, a privately held, employee-based ... of the Boston Globe’s “Top Places to Work 2014”. ... Massachusetts to receive the honor. , The Boston Globe’s ... of their most valuable resource: the people who work ... are based on an array of criteria, including the ...
(Date:11/15/2014)... November 14, 2014 The ... announced today that the society’s Governing Board has ... Edwards Lifesciences chief scientific officer and Dr. Charles ... officer, Abbott Vascular. Mr. Rowe and Dr. ... device development experts. , Dr. Nabil Dib, ...
Breaking Biology Technology:Great Basin Scientific Announces Conference Call to Provide Update on Corporate Progress 2Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 2Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 3Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 4Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 5Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 6Collaborative Consulting Honored with Boston Globe Top Places to Work 2014 2International Society for Cardiovascular Translational Research Governing Board Adds Medical Industry Leaders 2
... Group in North America with this Elevated Partner ... ... an Oracle System,Integrator, today announced it has achieved Oracle Certified Advantage,Partner status ... the highest level in the Oracle PartnerNetwork -- BIAS had,to demonstrate superior ...
... for the Long-Term Care Channel, BASKING ... wholly owned subsidiary of Millennium Biotechnologies,Group, Inc. ... the initial,$200,000.00 monthly shipment from Millennium Biotechnologies, ... the previously announced $20,000,000,Five- year exclusive Purchase ...
... Life Sciences R&D to ... Ensure Continued Growth, ... Authority (EDA) announced today that Tris Pharma, Inc. will,expand its ... bonds issued under the state,s Edison Innovation,Fund. Representatives from the ...
Cached Biology Technology:BIAS Achieves Certified Advantage Partner Level in Oracle PartnerNetwork 2BIAS Achieves Certified Advantage Partner Level in Oracle PartnerNetwork 3Millennium Ships and Records the First $200,000 of Revenue Generated From the Five-Year $20,000,000 Exclusive Purchase Order 2Millennium Ships and Records the First $200,000 of Revenue Generated From the Five-Year $20,000,000 Exclusive Purchase Order 3Edison Innovation Fund Helps Tris Pharma Expand 2Edison Innovation Fund Helps Tris Pharma Expand 3
(Date:11/7/2014)... Debra Auguste, associate professor, biomedical engineering, in the ... of New York, have identified a molecule that ... the most aggressive forms of breast cancer. , ... mortality rate owing to aggressive proliferation and metastasis ... Professor Auguste,s team, discovered the overexpression of intercellular ...
(Date:11/6/2014)... yet progress in preventing and treating migratory cancer ... challenging to design drugs that work against metastasis," ... at Harvard Medical School. , "Unfortunately, many ... , Gujral and colleagues have now identified a ... how metastasis begins. Their findings may also inform ...
(Date:11/5/2014)... RENO – Kelly Redmond has dedicated his career ... knowledge to a general audience. , As deputy ... Climate Center at Nevada,s Desert Research Institute, Redmond ... the management, application and dissemination of climate data ... Annual Fall Meeting in San Francisco on December ...
Breaking Biology News(10 mins):Migration negation 2Migration negation 3Nevada climatologist to be honored at AGU Fall Meeting for lifetime of public outreach 2
... position is a determinant of antiretroviral treatment effectiveness during ... even among subjects with high rates of drug adherence, ... issue of the Journal of Psychosomatic Research. The ... Harvard School of Public Health (HSPH), Massachusetts General Hospital, ...
... of rotten meat on the premises of a wholesaler in ... grocery stores everywhere is not to be underestimated, the importance ... reliable measurement methods that enable large numbers of samples to ... place in order to make comprehensive monitoring a reality. In ...
... of the GSF National Research Center for Environment ... Centres) the group is continuing to search for cellular ... a prion infection. In collaboration with colleagues from the ... the group used micro-array technologies micro-arrays are ...
Cached Biology News:Socioeconomic position associated with effectiveness of HIV drugs 2New method reveals substances on surfaces of any kind 2Prions and retroviruses -- an unholy alliance? 2
Mouse monoclonal antibody raised against a partial recombinant PASK. NCBI Entrez Gene ID = PASK...
Agarose II (Low Melt)...
...
... I can be used in intracellular staining ... cells and to serve as an antibody ... cell permeabilization is a reversible process, it ... the presence of saponin during intracellular staining. ...
Biology Products: